1 November 2018

The research projects on the role of magnesium in type 2 diabetes mellitus have been nominated for the James Lind Award.



The winners of the James Lind Award will be partially determined by a public vote via this link. The nomination is a reward for the work of Steef Kurstjens, Jeroen de Baaij and Joost Hoenderop, theme Renal disorders, who recently showed that hypomagesemia is present in 1 out of 3 type 2 diabetes mellitus patients. Recently, they published in Diabetologia that hypomagnesemia is a serious risk factor for the development of a disturbed lipid metabolism. 

Jury

The jury that is chaired by Prof. Renger Witkamp (professor nutrition and pharmacology, Wageningen University & Research) selected their research project from a very diverse group of research project. The jury selected their research on magnesium based on impact, innovation and scientific quality. Professor Witkamp states that among the nominees the projects are relevant for future practical use. 

James Lind Award

This inaugural James Lind Award has been initiated by the NPN (the society for nutrition supplements) to increase the awareness for scientific research on nutrition. The NPN aims to translate scientific practice in practical use. James Lind (1716-1794) was a physician that used components from nutrition (e.g. vitamins and minerals) for treatment of diseases. He worked on ships and discovered that he could prevent scurvy sing citrus fruits. He conducted one of the first ever clinical trials and was a pioneer of naval hygiene.

The winner of the James Lind Award will be determined by the jury (50%) and the results of a public vote (50%). 22 November the winners will be announced during the symposium ‘Gezondheidswinst met vitamines en mineralen’ in Maarssen.

Vote

Please support their research by voting via this link.

 

Related news items


Online intervention for women exposed to intimate partner violence

21 November 2019

Within the SAFE project from the department of Primary and Community Care an eHealth intervention has been developed for women exposed to intimate partner violence (IPV).

read more

A personal touch of Sander Leeuwenburgh

21 November 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Sander Leeuwenburgh.

read more

Technology for Oncology II grant application funded

21 November 2019

The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.

read more

KNCV Golden Master Award call for nominations

20 November 2019

The Royal Netherlands Chemistry Society awards this prize each year to the best Master’s research project. The Master’s thesis must relate to research in the field of chemistry, life sciences, process technology or (bio-)molecular sciences. Deadline: 31-12-2019.

read more

Podosome nanoscale architecture redefined

20 November 2019

Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications.

read more

270 times Homo Universalis in Nijmegen

20 November 2019

What does a scientist of the future look like? International young scientists addressed this important topic during the ENABLE conference, organized by young researchers for young researchers. They showed how the new generation of researchers wants to open up science to the public.

read more